Home » Newsletters » BioWorld Science

BioWorld Science

April 27, 2007

View Archived Issues

Neuromed licenses U.S. rights to OROS Hydromorphone

Preclinical profile of the kinase inhibitor R-1530 reported by Roche

Sciele Pharma to acquire Alliant Pharmaceuticals

Novartis delivers Coartem to Tanzania, continues malaria research

KSP inhibition with ARRY-520 shows antitumor activity in animal models of solid tumors

Promising antitumor activity of a novel nonlactone camptothecin derivative

Novel therapeutic agents for respiratory disorders disclosed in recent patent literature

Recent patents describe novel agents for psychopharmacological disorders

BAL-27862 shows promising antitumor activity in multidrug-resistant cancers

PKD inhibition with CRT-0059359 shows potent inhibition of cancer cell growth in vitro

Improved series of class I-selective HDAC inhibitors designed by IRBM/Merck

Novel treatment options for anemia disclosed in recent GSK patents

Enrollment ongoing in phase III study of Medidur for DME

VSF-173 studied in phase II for excessive sleepiness

MP-470 cleared to begin clinical testing

ALKS-27 begins phase IIa study in COPD

CHMP to recommend that occult indication be deleted from Visudyne E.U. label

Exelixis files IND for XL-765

New pediatric eczema study compares EpiCeram to Elidel

Findings from confirmatory study of Foscan in advanced head and neck cancer

BEMA Fentanyl meets primary endpoint in breakthrough cancer pain

XP-13512 shows improvements in RLS

CAM-2029 provides long-acting release of octreotide in phase I study

Preliminary data indicate HyCAMP delivers more cycles of therapy than irinotecan

Nesp approved in Japan

Istradefylline NDA filed for Parkinson's disease

GSK: active start to 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...